|
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical research trials and Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation clinical trial. Subjects often receive the most expert healthcare possible for their Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation  Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
For Condition: Hepatitis B
Status: Recruiting
Sponsor(s): Bristol-Myers Squibb ,
Synopsis: This is a phase IIIb comparitive study of entecavir 1.0 mg QD vs adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for up to 96 weeks.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 16 Years/
Genders: Both
Protocol Entry Criteria: Inclusion - CP score > 7 - HBV viremia Exclusion - ALT > 15 - HIV/HCV/HDV coinfection
Total Enrollment:
Location and Contact Information:
Local Institution *Recruiting*
Farmington, Connecticut,
United States
Recruiting
Local Institution *Recruiting*
Los Angeles, California,
United States
Recruiting
Local Institution *Recruiting*
Minneapolis, Minnesota,
United States
Recruiting
Local Institution *Recruiting*
Richmond, Virginia,
United States
Recruiting
Local Institution *Recruiting*
San Diego, California,
United States
Recruiting
Local Institution *Recruiting*
Oklahoma City, Oklahoma,
United States
Recruiting
Local Institution *Recruiting*
Boston, Massachusetts,
United States
Recruiting
Local Institution *Recruiting*
Orange, California,
United States
Recruiting
Local Institution *Recruiting*
Atlanta, Georgia,
United States
Recruiting
Local Institution *Recruiting*
Chicago, Illinois,
United States
Recruiting
Local Institution *Recruiting*
Honolulu, Hawaii,
United States
Recruiting
Local Institution *Recruiting*
Miami, Florida,
United States
Recruiting
Local Institution *Recruiting*
Louisville, Kentucky,
United States
Recruiting
Local Institution *Recruiting*
Philadelphia, Pennsylvania,
United States
Recruiting
Local Institution *Recruiting*
Indianapolis, Indiana,
United States
Recruiting
Local Institution *Recruiting*
Tucson, Arizona,
United States
Recruiting
Local Institution *Recruiting*
Royal Oak, Michigan,
United States
Recruiting
Local Institution *Recruiting*
Phoenix, Arizona,
United States
Recruiting
Local Institution *Recruiting*
New York City, New York,
United States
Recruiting
Local Institution *Recruiting*
Baltimore, Maryland,
United States
Recruiting
Local Institution *Recruiting*
Iowa City, Iowa,
United States
Recruiting
Local Institution *Recruiting*
Valhalla, New York,
United States
Recruiting
Local Institution *Recruiting*
San Francisco, California,
United States
Recruiting
Local Institution *Recruiting*
Dallas, Texas,
United States
Recruiting
Additional Information:
Study ID Numbers: AI463-048;
Study Start Date: July 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065507
Other Hepatitis B Studies:
1. Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
2. Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
3. Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients with Both HBV and HIV
4. Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
5. A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Related Studies:
Other Hepatitis B Clinical Trials
Other California Clinical Trials
Other San Francisco Clinical Trials
Comparison of Entecavir to Adefovir in chronic HBV patients with hepatic decompensation
|
|
|
|
|
|
|
|
